Skip to main content
. Author manuscript; available in PMC: 2016 Mar 9.
Published in final edited form as: Clin Immunol. 2015 Nov 6;162:37–44. doi: 10.1016/j.clim.2015.11.002

Fig. 6.

Fig. 6

Comparison of the complement inhibitory activity of Cp40 in human and NHP (rhesus and cynomolgus monkey) sera. The percentage of inhibition was calculated according to CDC results to compare the complement inhibitory activity of Cp40 on human and NHP sera. All data are expressed as means ± SEM (*P < 0.05, **P < 0.01 vs. both rhesus and cynomolgus monkeys; n = 3).